Analyst rates Plains All American Pipeline a Buy: its 7% yield and 1.61x coverage support distribution growth, though ...
I rate QCLN ETF a Hold because of long-term potential balanced against low EPS growth and poor performing holdings.
Visa and Mastercard seek approval of a proposed $38B swipe-fee settlement for 12M+ merchants, cutting fees by 0.1 percentage ...
Analyst rates AVDV a Hold: its 11.92x portfolio P/E may add stability and diversify US high-beta equities, while energy costs ...
Analyst rates Upwork a Hold as Q3 GSV and active clients each fell 10% year over year, with acquisition headwinds that could ...
Analyst rates Agilon Health a Hold with a $98 target, 14.6% below its $114.81 close, as risk-score-driven 2026 margin gains ...
Saab remains a Buy: a 2028 valuation supports a $74.35 target and around 20% upside, despite depressed aerospace and defense ...
Steve Feinberg reportedly steered Lockheed Martin and RTX toward longtime Goldman banker Jim Donovan for Pentagon weapons ...
Analyst rates Peloton a Sell: sub-2% churn and weak sign-ups pressure its subscriber base; shares may remain dead money ...
Analyst rates Gilead Sciences a Hold with a 12-month $130.69 target, implying 22.2% downside as shares trade at a premium to ...
Analyst reiterates a Buy on (ACHR): shares trade at 1.697x book, 41% below their five-year average, after falling over 40% ...
BNY Mellon Small/Mid Cap Growth Fund returned -11.95% in Q3 2026, trailing its benchmark. Read the full commentary and market ...